Preaching and practice: evidence-based medicine and the accountability of nephrologists within the health care system. The implications of the findings of the cost-saving potential of subcutaneous versus intravenous epoetin therapy.
Levin
Adeera
A
D017046:Cost Savings / Q000191:economics* / Q000592:standards; D003695:Delivery of Health Care / Q000191:economics*; D004921:Erythropoietin / Q000008:administration & dosage* / Q000191:economics / Q000627:therapeutic use*; D019317:Evidence-Based Medicine / Q000191:economics*; D006287:Health Planning Guidelines; D006801:Humans; D007275:Injections, Intravenous / Q000191:economics; D007279:Injections, Subcutaneous / Q000191:economics; D009398:Nephrology / Q000191:economics*; D010819:Physician's Role; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin